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Purpose of the study
HIV-related body changes may stigmatise patients, pro-
ducing erosion of self-image and self-esteem, problems in
social and sexual relations, anxiety and depression. The
purpose of our study was to evaluate gender differences in
the evolution of depression among patients attending a
metabolic clinic for lipodystrophy (LD) diagnosis and
treatment.
Methods
Patients referring to Modena and Reggio Emilia University
metabolic clinic, receiving multidisciplinary treatment for
face or body LD, were enrolled. At baseline, biochemical,
viro-immunological parameters, and LD diagnosis
according to MACS classification were collected. At base-
line and after 48 weeks, patients filled the Beck Depres-
sion Inventory Scale questionnaire (BDI, total possible
scores range from 0 to 63; mild depression 9–17, moder-
ate depression 18–29, severe depression above 30).
Summary of results
272 patients enrolled; 36.4% female; median age 47 (± 7)
years; CDC group C 28.7%. At baseline, 59.2% had unde-
tectable viral load and 91.9% had CD4 cell count above
200 cell/microl. 41.7% of patients had lipoatrophy, 2.6%
lipohypertrophy, and 43.8% mixed forms. 72.4% of
patients underwent surgical treatment for face lipoatro-
phy during the follow-up period (70.6% male, 29.4%
female). At baseline, women median (IQR) BDI score was
statistically significant higher than that of men: 13 (12) vs.
10 (10), p = 0.030. There was no statistically significant
difference in BDI baseline median score comparing
patients with or without LD and those with different
forms of LD. After 48 weeks BDI median score improved
significantly in the sample 11 (11) vs. 9.5 (12), p = 0.001,
and in male patients 10 (10) vs. 9 (11), p = 0.001, but not
significantly in women 13 (12) vs. 11 (14) p = 0.110, even
distinguishing women on menopause or not. Among
patients undergoing surgical treatment for face lipoatro-
phy, men only experienced a statistically significant
improvement of BDI in the follow-up period: women
12.5 (15.7) vs. 12 (13.2) p = 0.114 and men 11 (10) vs. 9
(10) p < 0.0001.
Conclusion
As demonstrated in the general population, women with
HIV infection seem to be more vulnerable than men to
experience more severe depression symptoms that still
remain even after face lipoatrophy treatment. This issue
underlines the need for new studies analyzing the gender
peculiarity of depression among patients with HIV infec-
tion.
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